The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine

被引:0
|
作者
Xiao-Yong Pu
Zhi-Ping Wang
Yi-Rong Chen
Xing-Huan Wang
Yi-Long Wu
Huai-Peng Wang
机构
[1] Guangdong Provincial People’s Hospital,Department of Urology
[2] Guangdong Provincial People’s Hospital,The Cancer Research Center
[3] Guangdong Provincial People’s Hospital,The Medical Research Center
[4] Lanzou University,Department of of Urology, The Second Hospital
关键词
Bladder cancer; Tumor marker; Survivin; Cytokeratin 20; Mucin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:659 / 665
页数:6
相关论文
共 50 条
  • [31] The Diagnostic Efficacy of Urinary Survivin and Hyaluronidase mRNA as Urine Markers in Patients with Bladder Cancer
    Eissa, Sanaa
    Badr, Soheir
    Barakat, Maged
    Zaghloul, Ashraf Saad
    Mohanad, Marwa
    CLINICAL LABORATORY, 2013, 59 (7-8) : 893 - 900
  • [32] Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology
    Daniely, Michal
    Rona, Roni
    Kaplan, Tal
    Olsfanger, Shirley
    Elboim, Lea
    Freiberger, Avner
    Lew, Sylvia
    Leibovitch, Ilan
    CANCER CYTOPATHOLOGY, 2007, 111 (06) : 517 - 524
  • [33] Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine
    Yasushi Nakai
    Toshiyuki Ozawa
    Fumiko Mizuno
    Sayuri Onishi
    Takuya Owari
    Syunta Hori
    Yosuke Morizawa
    Yosihiro Tatsumi
    Makito Miyake
    Nobumichi Tanaka
    Daisuke Tsuruta
    Kiyohide Fujimoto
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 2309 - 2316
  • [34] Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine
    Gleichenhagen, Jan
    Arndt, Christian
    Casjens, Swaantje
    Meinig, Carmen
    Gerullis, Holger
    Raiko, Irina
    Bruening, Thomas
    Ecke, Thorsten
    Johnen, Georg
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [35] Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine
    Nakai, Yasushi
    Ozawa, Toshiyuki
    Mizuno, Fumiko
    Onishi, Sayuri
    Owari, Takuya
    Hori, Syunta
    Morizawa, Yosuke
    Tatsumi, Yosihiro
    Miyake, Makito
    Tanaka, Nobumichi
    Tsuruta, Daisuke
    Fujimoto, Kiyohide
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (11) : 2309 - 2316
  • [36] Prognostic value of occult metastases detected by cytokeratin 20 and mucin 2 mRNA quantification in sentinel lymph nodes from colon cancer patients
    Nordgard, Oddmund
    Oltedal, Satu
    Aasprong, Ole Gunnar
    Soreide, Jon Arne
    Soreide, Kjetil
    Tjensvoll, Kjersti
    Gilje, Bjornar
    Heikkila, Reino
    Guriby, Marianne
    Lothe, Ragnhild A.
    Smaaland, Rune
    Korner, Hartwig
    CANCER RESEARCH, 2012, 72
  • [37] Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer
    Lee, KH
    YONSEI MEDICAL JOURNAL, 2001, 42 (01) : 14 - 18
  • [38] Cytokeratin-20 Immunocytochemistry in Voided Urine Cytology and Its Comparison With Nuclear Matrix Protein-22 and Urine Cytology in the Detection of Urothelial Carcinoma
    Srivastava, Ruchi
    Arora, Vinod Kumar
    Aggarwal, Seema
    Bhatia, Arati
    Singh, Navjeevan
    Agrawal, Vivek
    DIAGNOSTIC CYTOPATHOLOGY, 2012, 40 (09) : 755 - 759
  • [39] Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability than standard cytology in the diagnosis of transitional cell carcinoma of the bladder
    Melissourgos, ND
    Kastrinakis, NG
    Skolarikos, A
    Pappa, M
    Vassilakis, G
    Gorgoulis, VG
    Salla, C
    UROLOGY, 2005, 66 (03) : 536 - 541
  • [40] Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real‐time PCR
    Reza Yahyazadeh
    Davood Bashash
    Parisa Ghaffari
    Saeid Kord
    Ava Safaroghli-Azar
    Seyed H. Ghaffari
    BMC Urology, 21